Crisaborole: all 40 studies that test it

Page 1 of 1. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.

• Efficacy of Crisaborole 2% Ointment Versus Tacrolimus 0.1% Ointment in the Treatment of Intertriginous and/or Anogenital Psoriasis: A Prospective Randomized Controlled Study.Not yet recruitingNCT07892339Phase 3
• Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic EczemaNot yet recruitingNCT07438509Phase 4
• Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic DermatitisNot yet recruitingNCT07437534Phase 4
• Utilization of a Microdevice for Psoriasis and Atopic DermatitisNot yet recruitingNCT07352566Phase 4
• Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic DermatitisNot yet recruitingNCT07162896Phase 3
• Crisaborole Ointment for Skin Toxicity Induced by CetuximabRecruitingNCT06118047Phase 2
• Improvement In Scratch Behavior And Sleep In Patients With Atopic DermatitisTerminatedNCT05200403Phase 4Results posted
• A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic DermatitisTerminatedNCT04498403Phase 3Results posted
• Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic DermatitisCompletedNCT04360187Phase 3Results posted
• Skin bioMARkers for Atopic Eczema Therapy EvaluationCompletedNCT04194814Phase 2Results posted
• Study Evaluating Efficacy and Safety of Crisaborole in Adults With Stasis DermatitisCompletedNCT04091087Phase 2Results posted
• A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic DermatitisCompletedNCT04040192Phase 3Results posted
• Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic DermatitisCompletedNCT03954158Phase 2Results posted
• Steroid-reducing Effects of CrisaboroleCompletedNCT03832010Phase 4Results posted
• ASPIRE: PROs & Caregiver Burden in Children With Atopic DermatitisCompletedNCT03645057Phase 3Results posted
• A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic DermatitisCompletedNCT03567980Phase 4Results posted
• A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate ADTerminatedNCT03539601Phase 4Results posted
• A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic DermatitisCompletedNCT03356977Phase 4Results posted
• Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for MorpheaCompletedNCT03351114Phase 2Results posted
• A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic DermatitisCompletedNCT03260595Phase 1Results posted
• Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic DermatitisCompletedNCT03233529Phase 2Results posted
• Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic DermatitisCompletedNCT02118792Phase 3Results posted
• Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic DermatitisCompletedNCT02118766Phase 3Results posted
• Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic DermatitisCompletedNCT01652885Phase 1/2Results posted
• Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic DermatitisCompletedNCT01602341Phase 2Results posted
• Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic DermatitisCompletedNCT01301508Phase 2Results posted
• AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type PsoriasisCompletedNCT01300052Phase 2Results posted
• Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type PsoriasisCompletedNCT01029405Phase 2Results posted
• Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type PsoriasisCompletedNCT00759161Phase 2Results posted
• Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type PsoriasisCompletedNCT00755196Phase 2Results posted
• Crisaborole vs Fluticasone Propionate in Mild to Moderate Atopic DermatitisCompletedNCT07537751Not applicable
• Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in VitiligoCompletedNCT05298033Phase 2
• Characterizing Skin Microbiome Change in Atopic DermatitisCompletedNCT04800185Early Phase 1
• Topical Crisaborole in Patients with Alopecia AreataWithdrawnNCT04299503Phase 2
• Study of Crisaborole Ointment 2% in Mild to Moderate Atopic DermatitisStatus unknownNCT04214197Phase 4
• Response of Children With Atopic Dermatitis (Eczema) to EucrisaCompletedNCT04023084Phase 4
• Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic DermatitisCompletedNCT03868098Phase 4
• Safety Study of Ointment for the Treatment of Plaque-type PsoriasisCompletedNCT01258088Phase 1
• A Phase I Study to Assess Novel Cream in a Psoriasis Plaque TestCompletedNCT00763204Phase 1
• A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque TestCompletedNCT00762658Phase 1

← Crisaborole overview